Candesartan cilexetil-induced severe hepatotoxicity.
Explore this paper's citation graph
Summary
This is the first description of severe hepatotoxicity associated with ductopenia caused by an adverse reaction to candesartan cilexetil, 16 mg/d, for essential hypertension, reported in a 61-year-old woman.
- Type
- article
- Published
- 2003-03-01
- Cited by
- 29
- References
- 18
- OpenAlex
- https://openalex.org/W1970790071
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:198591
Keywords
Candesartan, Medicine, Cholestasis, Alagille syndrome, Jaundice
References
- Criteria of drug-induced liver disorders. Report of an international consensus meeting.
- Marked hepatotoxicity associated with losartan treatment.
- Risk Stratification after Myocardial Infarction
- Comment: Glucosamine: Selecting Appropriate Study Exclusion Criteria
- Losartan-induced hepatic injury.
- Vanishing bile duct syndrome in drug-induced liver disease.
- [Acute hepatitis induced by candesartan].
- Clinical Pharmacokinetics of Candesartan
- Drug points: prolonged cholestasis associated with irbesartan.
- Drug-induced liver diseases.
- Candesartan and acute liver injury
- Losartan-induced hepatotoxicity.
- Pancreatitis after losartan.
- [Drug-induced cholestasis].
- Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
- Losartan-Induced Acute Pancreatitis
- Losartan-induced hepatotoxicity
- Angiotensin receptor antagonists as a treatment for hypertension.
Cited by
- Drug-induced liver injury
- [Candesartan-induced cholestatic hepatitis: a case report].
- Can We Prevent Fatal Liver Failure under Valproate?
- Angiotensin II Protects Primary Rat Hepatocytes against Bile Salt-Induced Apoptosis
- Drug-induced liver disease in 2003
- Signal transduction pathways in hepatocyte cell death : new targets for therapy
- Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers
- Another Major Study on Adverse Events in the Ambulatory Setting Hepatotoxicity Caused by Angiotensin II Receptor Blockers Interferon Alfa Therapy and Psychosis Priapism with an Atypical Antipsychotic Update on Drug-Induced Thrombocytopenia
- Noncholestatic acute hepatocellular injury following candesartan administration
- Candesartan.
- Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers
- A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
- Drug-induced Liver Injury: Pathology Patterns and Common Culprits.
- Angiotensin-Converting Enzyme Inhibitor-Drug Induced Liver Injury: Clinical Features and Diagnostic Features – A Systematic Review of Current Reported Cases
- Liver Disease caused by drugs
- Chapter 25 – Drug-Induced Liver Injury
- 10 – Diseases of the bile ducts
- 28 – Loss of Intrahepatic Bile Ducts in Adults
- 20 - Antihypertensive drugs
- 9 – Bile Duct Diseases
Related papers
- CHARACTERIZATION OF THE RESOLUTION OF SEVERE CHOLESTASIS IN 11 CHILDREN WITH ALAGILLE SYNDROME
- Alagille syndrome: Is it always cholestasis?
- Progress of the causes of infantile cholestasis
- Alagille Syndrome: Resolution of Xanthomas
- Atypical causes of cholestasis.
- Cholestasis in infants
- Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.
- Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy.